Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Accriva Diagnostics, Inc. recalls Hemochron Jr.

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
Products
  • Hemochron Jr.
Where it was sold

Worldwide - US Nationwide distribution in the states of MA, MO, AK, WV, NJ, TX, VA, IL, NY and the countries of China, Colombia.

States: Alaska, Illinois, Massachusetts, Missouri, New Jersey, New York, Texas, Virginia, West Virginia

Barcodes
10711234103012
Units affected
28710
About this recall
Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103